Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus midazolam combined with dexmedetomidine and butorphanol for ERCP sedation in very elderly patients
ChiCTR2100049750Phase 4Recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, midazolam, dexmedetomidine and butorphanol in None (2 arms), sponsored by Renmin Hospital of Wuhan University. Primary endpoint: Success rate of procedure sedation. Started Aug 2021; status: recruiting.
02
Drugs
remimazolammidazolamdexmedetomidinebutorphanol
Beyond the preview
Go deeper on ChiCTR2100049750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049750.